US 11141393
Treatment of vasculopathy with prostacyclin and mesenchymal stem cells
granted A61KA61K31/557A61K31/5585
Quick answer
US patent 11141393 (Treatment of vasculopathy with prostacyclin and mesenchymal stem cells) held by United Therapeutics Corporation expires Mon Oct 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United Therapeutics Corporation
- Grant date
- Tue Oct 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/557, A61K31/5585, A61K35/28, A61P